DNA 시퀀싱 시장의 주요 분석 방법과 범위는 무엇인가요?

DNA 시퀀싱 시장의 분석 방법과 범위는 제1장 분석 방법·범위에서 다루어집니다.

DNA 시퀀싱 시장의 주요 요약은 어디에서 확인할 수 있나요?

DNA 시퀀싱 시장의 주요 요약은 제2장 주요 요약에서 확인할 수 있습니다.

DNA 시퀀싱 시장의 경쟁 구도는 어떻게 되나요?

DNA 시퀀싱 시장의 경쟁 구도는 제10장 경쟁 구도에서 다루어집니다.

시장보고서

상품코드

2089699

DNA 시퀀싱 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 워크플로우별, 용도별, 최종 용도별 및 부문별 예측(2026-2033년)

DNA Sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application, By End-use, And Segment Forecasts, 2026 - 2033

발행일: 2026년 06월 | 리서치사: 구분자

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950

￦ 8,864,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950

￦ 10,354,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 8,950

￦ 13,333,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

DNA 시퀀싱 시장 개요

세계의 DNA 시퀀싱 시장 규모는 2025년에 179억 달러로 평가되었으며, 2026년 217억 달러에서 2033년까지 919억 달러로 확대되어 2026년부터 2033년까지 CAGR 22.9%로 성장할 것으로 예측됩니다.

2025년 기준으로 북미 시장은 세계 시장 전체의 51.1%라는 최대 점유율을 차지했습니다. 이 시장의 꾸준한 성장은 차세대 시퀀싱 기술의 도입 확대, 종양학 및 희귀질환 진단 분야에서의 임상적 적용 증가, 그리고 전 세계 유전체 연구에 대한 투자 확대에 힘입어 이루어지고 있습니다.

자주 묻는 질문

DNA 시퀀싱 시장 규모는 어떻게 변화할 것으로 예상되나요?
- 2025년에 179억 달러, 2026년에 217억 달러, 2033년까지 919억 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 CAGR은 22.9%로 성장할 것으로 예측됩니다.
2025년 기준으로 북미의 DNA 시퀀싱 시장 점유율은 얼마인가요?
- 2025년 기준으로 북미 시장은 세계 시장 전체의 51.1%라는 최대 점유율을 차지했습니다.
DNA 시퀀싱 시장의 성장은 어떤 요인에 의해 이루어지고 있나요?
- 차세대 시퀀싱 기술의 도입 확대, 종양학 및 희귀질환 진단 분야에서의 임상적 적용 증가, 그리고 전 세계 유전체 연구에 대한 투자 확대에 힘입어 이루어지고 있습니다.
DNA 시퀀싱 시장의 주요 분석 방법과 범위는 무엇인가요?
- DNA 시퀀싱 시장의 분석 방법과 범위는 제1장 분석 방법·범위에서 다루어집니다.
DNA 시퀀싱 시장의 주요 요약은 어디에서 확인할 수 있나요?
- DNA 시퀀싱 시장의 주요 요약은 제2장 주요 요약에서 확인할 수 있습니다.
DNA 시퀀싱 시장의 경쟁 구도는 어떻게 되나요?
- DNA 시퀀싱 시장의 경쟁 구도는 제10장 경쟁 구도에서 다루어집니다.

The global DNA sequencing market size was valued at USD 17.9 billion in 2025 and is projected to grow from USD 21.7 billion in 2026 to USD 91.9 billion by 2033, growing at a CAGR of 22.9% from 2026 to 2033. The North America market held the largest share of 51.1% of the global market in 2025. The market's steady growth is driven by rising adoption of next generation sequencing technologies, increasing clinical applications in oncology and rare disease diagnostics, and expanding investments in genomics research globally.

Global DNA Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the DNA sequencing market on the basis of product and services, technology, workflow, application, end-use and region:

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Consumables
Services
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Sanger Sequencing
Next-Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing & Resequencing
Third Generation Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Pre-sequencing
Sequencing
Data Analysis
Application Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Reproductive Health
Clinical Investigation
Agrigenomics & Forensics
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Consumer Genomics
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic Research
Clinical Research
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other Users
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Information analysis
- 1.2.2. Market formulation & data visualization
- 1.2.3. Data validation & publishing
1.3. Information Procurement
- 1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
- 1.7.1. Objective 1
- 1.7.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Derivers
- 3.3.1. Increasing adoption of DNA vaccines
- 3.3.2. Declining cost of genome sequencing
3.4. Market Restraint Analysis
- 3.4.1. Regulatory and quality compliance challenges
3.5. Business Environment Analysis
- 3.5.1. PESTEL Analysis
- 3.5.2. Porter's Five Forces Analysis

Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis

4.1. Global DNA Sequencing Market: Product & Service Movement Analysis
4.2. Consumables
- 4.2.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
4.3. Instruments
- 4.3.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.4. Services
- 4.4.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis

5.1. Global DNA Sequencing market: Technology Movement Analysis
5.2. Sanger sequencing
- 5.2.1. Sanger sequencing market estimates and forecasts 2021 to 2033 (USD Million)
5.3. Next-generation sequencing (NGS)
- 5.3.1. Next-generation sequencing (NGS) market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.2. Whole genome sequencing (WGS)
  - 5.3.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3. Whole exome sequencing (WES)
  - 5.3.3.1. Whole exome sequencing (WES) market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.4. Targeted sequencing & resequencing
  - 5.3.4.1. Targeted sequencing & resequencing market estimates and forecasts 2021 to 2033 (USD Million)
5.4. Third generation DNA sequencing
- 5.4.1. Third generation dna sequencing market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Single-molecule real-time sequencing (SMRT)
  - 5.4.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.3. Nanopore sequencing
  - 5.4.3.1. Nanopore sequencing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis

6.1. Global DNA Sequencing market: Workflow Movement Analysis
6.2. Pre-sequencing
- 6.2.1. Pre-sequencing market estimates and forecasts 2021 to 2033 (USD Million)
6.3. Sequencing
- 6.3.1. Sequencing Market estimates and forecasts 2021 to 2033 (USD Million)
6.4. Data Analysis
- 6.4.1. Data analysis Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis

7.1. Global DNA Sequencing Market: Application Movement Analysis
7.2. Oncology
- 7.2.1. Oncology Market estimates and forecasts 2021 to 2033 (USD Million)
7.3. Reproductive Health
- 7.3.1. Reproductive health market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Clinical Investigation
- 7.4.1. Clinical investigation Market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Agrigenomics & Forensics
- 7.5.1. Agrigenomics & forensics market estimates and forecasts 2021 to 2033 (USD Million)
7.6. HLA Typing/Immune System Monitoring
- 7.6.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Metagenomics, Epidemiology, & Drug Development
- 7.7.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Consumer Genomics
- 7.8.1. Consumer genomics market estimates and forecasts 2021 to 2033 (USD Million)
7.9. Others
- 7.9.1. Others Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis

8.1. Global DNA Sequencing Market: End-use Movement Analysis
8.2. Academic Research
- 8.2.1. Academic research market estimates and forecasts 2021 to 2033 (USD Million)
8.3. Clinical Research
- 8.3.1. Clinical research market estimates and forecasts 2021 to 2033 (USD Million)
8.4. Hospitals & Clinics
- 8.4.1. Hospitals & clinics market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Pharmaceutical & Biotechnology Companies
- 8.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Others
- 8.6.1. Others Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Global DNA sequencings market Share By Region, 2025 & 2033
9.2. North America
- 9.2.1. North America DNA sequencings market, 2021 - 2033 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. Key Country Dynamics
  - 9.2.2.2. Competitive Scenario
  - 9.2.2.3. Regulatory Framework
  - 9.2.2.4. Target Disease Prevalence
  - 9.2.2.5. U.S. DNA sequencings market, 2021 - 2033 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Key Country Dynamics
  - 9.2.3.2. Competitive Scenario
  - 9.2.3.3. Regulatory Framework
  - 9.2.3.4. Target Disease Prevalence
  - 9.2.3.5. Canada DNA sequencings market, 2021 - 2033 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Key Country Dynamics
  - 9.2.4.2. Competitive Scenario
  - 9.2.4.3. Regulatory Framework
  - 9.2.4.4. Target Disease Prevalence
  - 9.2.4.5. Mexico DNA sequencings market, 2021 - 2033 (USD Million)
9.3. Europe
- 9.3.1. Europe DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.2. Germany
  - 9.3.2.1. Key Country Dynamics
  - 9.3.2.2. Competitive Scenario
  - 9.3.2.3. Regulatory Framework
  - 9.3.2.4. Target Disease Prevalence
  - 9.3.2.5. Germany DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.3. UK
  - 9.3.3.1. Key Country Dynamics
  - 9.3.3.2. Competitive Scenario
  - 9.3.3.3. Regulatory Framework
  - 9.3.3.4. Target Disease Prevalence
  - 9.3.3.5. UK DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.4. France
  - 9.3.4.1. Key Country Dynamics
  - 9.3.4.2. Competitive Scenario
  - 9.3.4.3. Regulatory Framework
  - 9.3.4.4. Target Disease Prevalence
  - 9.3.4.5. France DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Key Country Dynamics
  - 9.3.5.2. Competitive Scenario
  - 9.3.5.3. Regulatory Framework
  - 9.3.5.4. Target Disease Prevalence
  - 9.3.5.5. Italy DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Key Country Dynamics
  - 9.3.6.2. Competitive Scenario
  - 9.3.6.3. Regulatory Framework
  - 9.3.6.4. Target Disease Prevalence
  - 9.3.6.5. Spain DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Key Country Dynamics
  - 9.3.7.2. Competitive Scenario
  - 9.3.7.3. Regulatory Framework
  - 9.3.7.4. Target Disease Prevalence
  - 9.3.7.5. Denmark DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Key Country Dynamics
  - 9.3.8.2. Competitive Scenario
  - 9.3.8.3. Regulatory Framework
  - 9.3.8.4. Target Disease Prevalence
  - 9.3.8.5. Sweden DNA sequencings market, 2021 - 2033 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Key Country Dynamics
  - 9.3.9.2. Competitive Scenario
  - 9.3.9.3. Regulatory Framework
  - 9.3.9.4. Target Disease Prevalence
  - 9.3.9.5. Norway DNA sequencings market, 2021 - 2033 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.2. Japan
  - 9.4.2.1. Key Country Dynamics
  - 9.4.2.2. Competitive Scenario
  - 9.4.2.3. Regulatory Framework
  - 9.4.2.4. Target Disease Prevalence
  - 9.4.2.5. Japan DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.3. China
  - 9.4.3.1. Key Country Dynamics
  - 9.4.3.2. Competitive Scenario
  - 9.4.3.3. Regulatory Framework
  - 9.4.3.4. Target Disease Prevalence
  - 9.4.3.5. China DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.4. India
  - 9.4.4.1. Key Country Dynamics
  - 9.4.4.2. Competitive Scenario
  - 9.4.4.3. Regulatory Framework
  - 9.4.4.4. Target Disease Prevalence
  - 9.4.4.5. India DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.5. South Korea
  - 9.4.5.1. Key Country Dynamics
  - 9.4.5.2. Competitive Scenario
  - 9.4.5.3. Regulatory Framework
  - 9.4.5.4. Target Disease Prevalence
  - 9.4.5.5. South Korea DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.6. Australia
  - 9.4.6.1. Key Country Dynamics
  - 9.4.6.2. Competitive Scenario
  - 9.4.6.3. Regulatory Framework
  - 9.4.6.4. Target Disease Prevalence
  - 9.4.6.5. Australia DNA sequencings market, 2021 - 2033 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Key Country Dynamics
  - 9.4.7.2. Competitive Scenario
  - 9.4.7.3. Regulatory Framework
  - 9.4.7.4. Target Disease Prevalence
  - 9.4.7.5. Thailand DNA sequencings market, 2021 - 2033 (USD Million)
9.5. Latin America
- 9.5.1. Latin America DNA sequencings market, 2021 - 2033 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Key Country Dynamics
  - 9.5.2.2. Competitive Scenario
  - 9.5.2.3. Regulatory Framework
  - 9.5.2.4. Target Disease Prevalence
  - 9.5.2.5. Brazil DNA sequencings market, 2021 - 2033 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Key Country Dynamics
  - 9.5.3.2. Competitive Scenario
  - 9.5.3.3. Regulatory Framework
  - 9.5.3.4. Target Disease Prevalence
  - 9.5.3.5. Argentina DNA sequencings market, 2021 - 2033 (USD Million)
9.6. MEA
- 9.6.1. MEA DNA sequencings market, 2021 - 2033 (USD Million)
- 9.6.2. South Africa
  - 9.6.2.1. Key Country Dynamics
  - 9.6.2.2. Competitive Scenario
  - 9.6.2.3. Regulatory Framework
  - 9.6.2.4. Target Disease Prevalence
  - 9.6.2.5. South Africa DNA sequencings market, 2021 - 2033 (USD Million)
- 9.6.3. Saudi Arabia
  - 9.6.3.1. Key Country Dynamics
  - 9.6.3.2. Competitive Scenario
  - 9.6.3.3. Regulatory Framework
  - 9.6.3.4. Target Disease Prevalence
  - 9.6.3.5. Saudi Arabia DNA sequencings market, 2021 - 2033 (USD Million)
- 9.6.4. UAE
  - 9.6.4.1. Key Country Dynamics
  - 9.6.4.2. Competitive Scenario
  - 9.6.4.3. Regulatory Framework
  - 9.6.4.4. Target Disease Prevalence
  - 9.6.4.5. UAE DNA sequencings market, 2021 - 2033 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Key Country Dynamics
  - 9.6.5.2. Competitive Scenario
  - 9.6.5.3. Regulatory Framework
  - 9.6.5.4. Target Disease Prevalence
  - 9.6.5.5. Kuwait DNA sequencings market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market/Position Share Analysis, 2025
10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific, Inc
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product & service benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. Agilent Technology
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product & service benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. Illumina, Inc.
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product & service benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. QIAGEN
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product & service benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. F. Hoffmann-La Roche Ltd.
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product & service benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Oxford Nanopore Technologies plc.
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product & service benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Macrogen, Inc.
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product & service benchmarking
  - 10.4.7.4. Strategic initiatives
- 10.4.8. PerkinElmer Genomics
  - 10.4.8.1. Company overview
  - 10.4.8.2. Financial performance
  - 10.4.8.3. Product & service benchmarking
  - 10.4.8.4. Strategic initiatives
- 10.4.9. PacBio
  - 10.4.9.1. Company overview
  - 10.4.9.2. Financial performance
  - 10.4.9.3. Product & service benchmarking
  - 10.4.9.4. Strategic initiatives
- 10.4.10. BGI
  - 10.4.10.1. Company overview
  - 10.4.10.2. Financial performance
  - 10.4.10.3. Product & service benchmarking
  - 10.4.10.4. Strategic initiatives
- 10.4.11. Bio-Rad Laboratories, Inc.
  - 10.4.11.1. Company overview
  - 10.4.11.2. Financial performance
  - 10.4.11.3. Product & service benchmarking
  - 10.4.11.4. Strategic initiatives
- 10.4.12. Myriad Genetics
  - 10.4.12.1. Company overview
  - 10.4.12.2. Financial performance
  - 10.4.12.3. Product & service benchmarking
  - 10.4.12.4. Strategic initiatives
- 10.4.13. PierianDx
  - 10.4.13.1. Company overview
  - 10.4.13.2. Financial performance
  - 10.4.13.3. Product & service benchmarking
  - 10.4.13.4. Strategic initiatives
- 10.4.14. Partek Incorporated
  - 10.4.14.1. Company overview
  - 10.4.14.2. Financial performance
  - 10.4.14.3. Product & service benchmarking
  - 10.4.14.4. Strategic initiatives
- 10.4.15. Eurofins Scientific
  - 10.4.15.1. Company overview
  - 10.4.15.2. Financial performance
  - 10.4.15.3. Product & service benchmarking
  - 10.4.15.4. Strategic initiatives

DNA 시퀀싱 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 워크플로우별, 용도별, 최종 용도별 및 부문별 예측(2026-2033년)